Caspase activity a novel biomarker for NAFLD severity

被引：3
|
作者：
Lang, Les
机构：
来源：
GASTROENTEROLOGY | 2006年 / 131卷 / 02期
关键词：
D O I：
10.1053/j.gastro.2006.06.031
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：344 / 344
页数：1
相关论文
共 50 条
  • [11] Caspase activity in lymphocytes of patients with depression and anxiety of different severity
    Yakovlev A.A.
    Druzhkova T.A.
    Grishkina M.N.
    Guekht A.B.
    Gulyaeva N.V.
    Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 2017, 11 (1) : 76 - 80
  • [12] Urinary Follistatin: A Novel Biomarker for Monitoring the Severity of AKI
    Nagayama, Izumi
    Nagata, Daisuke
    Hasegawa, Hajime
    Maeshima, Akito
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 126 - 126
  • [13] Adiponectin as a novel biomarker of disease severity in alopecia areata
    Anna Stochmal
    Anna Waśkiel-Burnat
    Sylwia Chrostowska
    Michał Zaremba
    Adriana Rakowska
    Joanna Czuwara
    Lidia Rudnicka
    Scientific Reports, 11
  • [14] Adiponectin as a novel biomarker of disease severity in alopecia areata
    Stochmal, Anna
    Waskiel-Burnat, Anna
    Chrostowska, Sylwia
    Zaremba, Michal
    Rakowska, Adriana
    Czuwara, Joanna
    Rudnicka, Lidia
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [15] THE ANALYTICAL AND CLINICAL VALIDATION OF CASPASE CLEAVED KERATIN 18 FRAGMENTS, M30® AS A PROMISING NAFLD BIOMARKER
    Paglialunga, Sabina
    Jaycox, Sharon
    Tuohy, Jessica
    Hambleton, Michael
    Kar, Sumit
    HEPATOLOGY, 2020, 72 : 946 - 946
  • [16] Correction to: Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis
    David Bennett
    Paolo Cameli
    Nicola Lanzarone
    Loredana Carobene
    Nicola Bianchi
    Annalisa Fui
    Luigi Rizzi
    Laura Bergantini
    Giuseppe Cillis
    Miriana d’Alessandro
    Maria Antonietta Mazzei
    Rosa Metella Refini
    Piersante Sestini
    Elena Bargagli
    Paola Rottoli
    Respiratory Research, 21
  • [17] A plasma biomarker of neutrophilic activity correlates with COPD severity
    Joglekar, Mugdha M.
    Sand, Jannie M. B.
    Leeming, Diana J.
    Klont, Frank
    Bowler, Russell P.
    Melgert, Barbro N.
    Pouwels, Simon D.
    Burgess, Janette K.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [18] Circulating fibroblast activation protein enzyme activity as a biomarker of liver fibrosis in NAFLD
    Hannah, N.
    Kemp, W.
    Crest, P.
    Roberts, S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 102 - 103
  • [19] CIRCULATING HEPATIC EXOSOMAL miR122 AS A BIOMARKER OF NAFLD/ NASH ACTIVITY
    Rouster, Susan D.
    Jennings, Carrie
    Sherman, Kenneth E.
    HEPATOLOGY, 2023, 78 : S781 - S782
  • [20] Serum apoptotic caspase activity as marker of disease severity in chronic hepatitis C (CH-C) or non-alcoholic fatty liver disease (NAFLD)
    Papatheodoridis, G. V.
    Hadziyannis, E.
    Tsochatzis, E.
    Chrysanthos, N.
    Georgiou, A.
    Kafiri, G.
    Manolakopoulos, S.
    Manesis, E. K.
    Archimandritis, A. J.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S282 - S282
12345